Russell Investments Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-120,186
Closed -$390K 3328
2021
Q1
$390K Sell
120,186
-88,782
-42% -$318K ﹤0.01% 2618
2020
Q4
$711K Sell
208,968
-81,272
-28% -$334K ﹤0.01% 2278
2020
Q3
$1.18M Buy
290,240
+112,780
+64% +$429K ﹤0.01% 1987
2020
Q2
$598K Buy
177,460
+47,873
+37% +$139K ﹤0.01% 2315
2020
Q1
$301K Sell
129,587
-65,189
-33% -$178K ﹤0.01% 2396
2019
Q4
$707K Buy
194,776
+34,114
+21% +$276K ﹤0.01% 2277
2019
Q3
$1.33M Buy
+160,662
New +$1.3M ﹤0.01% 1870
2017
Q2
Sell
-144,894
Closed -$942K 3064
2017
Q1
$942K Buy
144,894
+100,745
+228% +$563K ﹤0.01% 2130
2016
Q4
$196K Buy
+44,149
New +$185K ﹤0.01% 2723

Other funds holding SPPI

Russell Investments Group's SPPI Position: Q2 2021 in Review

Russell Investments Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2021, closing a stake of 120,186 shares — an estimated $390K sold.

Russell Investments Group first reported a position in SPPI in Q4 2016 and held it in 9 quarters. The position peaked at $1.33M in Q3 2019. 156 funds tracked by Wall St. Rank hold SPPI as of Q2 2021.

  • Russell Investments Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 120,186 Spectrum Pharmaceuticals Inc shares in Q2 2021, an estimated $390K.
  • Russell Investments Group first reported a position in Spectrum Pharmaceuticals Inc in Q4 2016 and held it in 9 quarters.
  • Russell Investments Group's Spectrum Pharmaceuticals Inc position peaked at $1.33M in Q3 2019.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.